Biora Therapeutics (NASDAQ:BIOR) Trading Down 14.2% – Time to Sell?

Biora Therapeutics, Inc. (NASDAQ:BIOR) shares dropped 14.2% during trading on Monday . The company traded as low as $0.15 and last traded at $0.16. Approximately 5,826 shares were traded during trading, a decline of 90% from the average daily volume of 58,319 shares. The stock had previously closed at $0.19.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright boosted their price target on Biora Therapeutics from $15.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, November 18th.

Biora Therapeutics Price Performance

The stock has a market capitalization of $741,772.00, a price-to-earnings ratio of -0.01 and a beta of 1.12. The stock has a 50-day moving average of $0.94 and a 200 day moving average of $4.09.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.